Trial intelligence / Profile preview

Gemcitabine/Abraxane and Radiotherapy for Locally Advanced Pancreatic Cancer

NCT01693276Phase 2Terminated

Start
Sep 2012
Primary completion
Jun 2014
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nab-paclitaxel in pancreatic carcinoma. Started Sep 2012; status: terminated.

02

Drugs

nab-paclitaxel
03

Conditions

pancreatic carcinoma

Beyond the preview

Go deeper on NCT01693276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01693276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call